- Home
- RDHL vs CHNR Comparison
RDHL vs CHNR Comparison
Compare RDHL & CHNR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RDHL
- CHNR
- Stock Information
- Founded
- RDHL 2009
- CHNR N/A
- Country
- RDHL Israel
- CHNR Hong Kong
- Employees
- RDHL N/A
- CHNR N/A
- Industry
- RDHL Biotechnology: Pharmaceutical Preparations
- CHNR Precious Metals
- Sector
- RDHL Health Care
- CHNR Basic Materials
- Exchange
- RDHL Nasdaq
- CHNR Nasdaq
- Market Cap
- RDHL 7.5M
- CHNR 6.1M
- IPO Year
- RDHL N/A
- CHNR 1995
- Fundamental
- Price
- RDHL $5.64
- CHNR $0.62
- Analyst Decision
- RDHL
- CHNR
- Analyst Count
- RDHL 0
- CHNR 0
- Target Price
- RDHL N/A
- CHNR N/A
- AVG Volume (30 Days)
- RDHL 13.8K
- CHNR 388.5K
- Earning Date
- RDHL 08-29-2024
- CHNR 01-01-0001
- Dividend Yield
- RDHL N/A
- CHNR N/A
- EPS Growth
- RDHL N/A
- CHNR N/A
- EPS
- RDHL N/A
- CHNR N/A
- Revenue
- RDHL $3,707,000.00
- CHNR N/A
- Revenue This Year
- RDHL $224.90
- CHNR N/A
- Revenue Next Year
- RDHL $82.69
- CHNR N/A
- P/E Ratio
- RDHL N/A
- CHNR N/A
- Revenue Growth
- RDHL N/A
- CHNR N/A
- 52 Week Low
- RDHL $5.41
- CHNR $0.51
- 52 Week High
- RDHL $31.50
- CHNR $8.85
- Technical
- Relative Strength Index (RSI)
- RDHL 35.38
- CHNR 49.36
- Support Level
- RDHL $5.41
- CHNR $0.62
- Resistance Level
- RDHL $5.79
- CHNR $0.79
- Average True Range (ATR)
- RDHL 0.31
- CHNR 0.07
- MACD
- RDHL -0.05
- CHNR -0.01
- Stochastic Oscillator
- RDHL 14.26
- CHNR 26.09
About RDHL Redhill Biopharma Ltd.
Redhill Biopharma Ltd is a specialty biopharmaceutical company focused on gastrointestinal diseases. The company is focused primarily on the advancement of its development pipeline of clinical-stage therapeutic candidates. The company also commercializes in the U.S. GI-related products, Talicia (omeprazole, amoxicillin, and rifabutin) and Aemcolo (rifamycin). The company's current pipeline consists of five therapeutic candidates, which are Opaganib, RHB-107, RHB-102, RHB-204, and RHB-104, most of which are in clinical development.
About CHNR China Natural Resources Inc.
China Natural Resources Inc is an investment holding company. It principally engaged in the exploration and mining and wastewater treatment businesses in the People's Republic of China. The company has two operating segments: (i) Wastewater treatment segment, which consists of sales of assembled equipment, provision of construction service, and participation in PPP projects as an operator (ii) Exploration and mining segment, which consists of the exploration of lead, silver, and other metals in the Inner Mongolia Autonomous Region of the PRC and the trading of copper ores products. It earns the majority of its revenue from the Wastewater treatment segment.